Medtech Europe：2022年欧洲体外诊断(IVD)市场数据统计报告（英文版）（9页）.pdf

《Medtech Europe：2022年欧洲体外诊断(IVD)市场数据统计报告（英文版）（9页）.pdf》由会员分享，可在线阅读，更多相关《Medtech Europe：2022年欧洲体外诊断(IVD)市场数据统计报告（英文版）（9页）.pdf（9页珍藏版）》请在三个皮匠报告上搜索。

1、EuropeanIVD MarketStatisticsReport2022 MEDTECH EUROPE EUROPEAN IVD MARKET STATISTICS REPORT 20221OverviewMedTech Europe is pleased to publish the market estimates of the In vitro diagnostic(IVD)industry in Europe.The MedTech Europe figures include market size and dynamics information,based on 2021 a

2、nd 2020 data.Macroeconomic and healthcare data are also included for the EU27-member states plus the European Free Trade Association members(EFTA)Switzerland,Norway and Iceland,and Switzerland,as well as for the United Kingdom and Turkey.In vitro diagnostics(IVDs)are an essential part of todays heal

3、thcare.Results of in vitro testing influence as many as 70%of clinical decisions,while IVDs account for just 1%of total healthcare expenditure in the EU-27,UK and EFTA.They play a vital role in in the response to COVID-19.A critical element for combatting the COVID-19 pandemic is to have suitable di

4、agnostic tests available.Furthermore,IVDs are used to diagnose,monitor,screen and assess predispositions to diseases,thereby contributing to the available medical information regarding a patient.By allowing earlier and more targeted treatments,IVDs help to reduce hospital stays and convalescences,re

5、sulting in healthier populations,reduced costs,and economic growth in the long run.Since 2013,the IVD market has been stagnant with slight growth.In 2020,however,due to the COVID-19 pandemic and the high demands for SARS-Cov-2 testing,the IVD market has experienced an increase of+25,4%.In 2021,we wi

6、tness an unprecedented record growth of 41.2%.Overall revenues across EU-27,UK and EFTA reached 20,670 million.When looking beyond the COVID-19 related diagnostics and comparing to 2020,there have been clear signs of recovery in most tests in the other IVD segments such as clinical chemistry,immunol